Both in Biotechnology
VivoSim Labs vs PharmaCyte Biotech
Over the past year VIVS returned −93.6% and PMCB returned −66.0%; their daily moves had a correlation of 0.10.
VIVS −93.6% PMCB −66.0%Growth of $1, one year, split-adjusted
| Metric | VIVS | PMCB |
|---|---|---|
| Price | $0.1457 | $0.3347 |
| Market cap | $2.0M | $3.6M |
| Today | −3.06% | −2.45% |
| 1 month | −28.0% | −20.1% |
| 6 months | −89.9% | −55.4% |
| Year to date | −92.0% | −53.8% |
| 1 year | −93.6% | −66.1% |
| Revenue growth (YoY) | −51.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −7433.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 17.4× | — |
| Net cash | $1.7M | $30.5M |
| Dividend yield | — | — |
| Volatility (60d) | 116.0% | 61.5% |
| Short % of float | 4.0% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).